Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant
Sharon L. Hillier, Ph.D., Robert P. Nugent, Ph.D., David A. Eschenbach, M.D., Marijane A. Krohn, Ph.D., Ronald S. Gibbs, M.D., David H. Martin, M.D., Mary Frances Cotch, Ph.D., Robert Edelman, M.D., Joseph G. Pastorek, M.D., A. Vijaya Rao, Ph.D., Donald McNellis, M.D., Joan A. Regan, M.D., J. Christopher Carey, M.D., Mark A. Klebanoff, M.D., for The Vaginal Infections and Prematurity Study Group
Background Bacterial vaginosis is believed to be a risk factorfor preterm delivery. We undertook a study of the associationbetween bacterial vaginosis and the preterm delivery of infantswith low birth weight after accounting for other known riskfactors.
Methods In this cohort study, we enrolled 10,397 pregnant womenfrom seven medical centers who had no known medical risk factorsfor preterm delivery. At 23 to 26 weeks' gestation, bacterialvaginosis was determined to be present or absent on the basisof the vaginal pH and the results of Gram's staining. The principaloutcome variable was the delivery at less than 37 weeks' gestationof an infant with a birth weight below 2500 g.
Results Bacterial vaginosis was detected in 16 percent of the10,397 women. The women with bacterial vaginosis were more likelyto be unmarried, to be black, to have low incomes, and to havepreviously delivered low-birth-weight infants. In a multivariateanalysis, the presence of bacterial vaginosis was related topreterm delivery of a low-birth-weight infant (odds ratio, 1.4;95 percent confidence interval, 1.1 to 1.8). Other risk factorsthat were significantly associated with such a delivery in thispopulation were the previous delivery of a low-birth-weightinfant (odds ratio, 6.2; 95 percent confidence interval, 4.6to 8.4), the loss of an earlier pregnancy (odds ratio, 1.7;1.3 to 2.2), primigravidity (odds ratio, 1.6; 1.1 to 1.9), smoking(odds ratio, 1.4; 1.1 to 1.7); and black race (odds ratio, 1.4;1.1 to 1.7). Among women with bacterial vaginosis, the highestrisk of preterm delivery of a low-birth-weight infant was foundamong those with both vaginal bacteroides and Mycoplasmahominis(odds ratio, 2.1; 95 percent confidence interval, 1.5 to 3.0).
Conclusions Bacterial vaginosis was associated with the pretermdelivery of low-birth-weight infants independently of otherrecognized risk factors.
Preterm delivery, low birth weight, and neonatal mortality arethe most important problems in obstetrics. From 1970 to 1985,the incidence of low birth weight in the United States declinedsteadily. From 1986 to 1991, however, the incidence of prematurebirth of low-birth-weight infants (those born at less than 37weeks' gestation, weighing less than 2500 g) increased from6.8 percent to 7.1 percent.1 Black race, low socioeconomic status,older maternal age, and previous preterm delivery have beenconsistently related to the preterm delivery of low-birth-weightinfants.2 In 1991, disorders related to preterm delivery andlow birth weight were the primary cause of death in the UnitedStates among black infants and the third leading cause of deathamong white infants.3
Bacterial vaginosis is a condition in which the normal, lactobacillus-predominantvaginal flora is replaced with anaerobic bacteria, Gardnerellavaginalis, and Mycoplasmahominis.4 Bacterial vaginosis hasbeen associated with preterm delivery,5,6,7,8,9,10 prematurerupture of membranes,5,7 infection of the chorion and amnion,11histologic chorioamnionitis,11 and infection of amniotic fluid.12,13,14In other reports, the microflora associated with bacterial vaginosis,including anaerobic gram-negative rods, G. vaginalis, and M.hominis, has been linked to preterm delivery.15,16,17
In a multicenter study, we followed a large cohort of pregnantwomen from five U.S. cities and investigated a large numberof risk factors and genital microorganisms for their associationwith the preterm delivery of low-birth-weight infants.18 Thepurpose of the study was to evaluate the association betweenthe incidence of such deliveries and that of bacterial vaginosisin this cohort.
Methods
Study Patients
A total of 13,914 women were enrolled at seven medical centersbetween 1984 and 1989. Of these, 2449 were excluded becauseof previous enrollment in another clinical trial.18 The inclusionof those women would not have altered our findings, but theywere excluded both for clarity of presentation and because ofthe possibility that bias might have been introduced becausethe women enrolled in the other study had a different follow-up.An additional 509 women were excluded because information aboutthe results of vaginal Gram's staining or pH measurement wasmissing, and 559 more women were excluded because data on birthoutcomes were missing. A total of 10,397 women remained in thestudy. All questionnaires were administered and all examinationsand microbiologic procedures were performed according to a standardizedprotocol. Samples containing unidentified organisms were usedto confirm the adequacy of the testing methods employed at eachcenter.
Women were enrolled in the study during routine prenatal visitsafter 23 to 26 weeks of gestation had been completed; for eachwoman, a medical, obstetrical, sexual, and social history wastaken and cultures of the vagina and cervix were obtained. Thereasons for exclusion from the study were age less than 16 years,Rh isoimmunization, use of antibiotics in the preceding twoweeks, multiple gestation, cervical cerclage, prior use of tocolyticagents during the current pregnancy, hypertension requiringtreatment with medication, insulin-dependent diabetes, currentuse of corticosteroids, chronic renal or symptomatic organicheart disease, and the intention to deliver at a nonstudy hospital.The women gave written informed consent, and the protocol wasapproved by the institutional review board at each center.
Collection of Specimens
A clean, unlubricated speculum was placed in the vagina, andthe vaginal pH was measured with pH strips (ColorpHast, MCBReagents, Gibbstown, N.J.). Sterile cotton swabs were used toobtain material from the posterior vaginal fornix for a vaginalsmear. A sterile, oxygen-reduced solution of phosphate-bufferedsaline (3 ml) was placed in the vagina, and a wash suspensionwas prepared by swabbing the lateral vaginal walls. The suspensionwas then removed with a syringe and injected into an oxygen-freetube for transport. A cervical specimen was obtained. The methodsused to detect microbiologic organisms have been described elsewhere.19
Because anaerobic, gram-negative rods have been reported aspart of the normal flora of most women,4 such organisms wereidentified only when they were found in the third or fourthstreak zone of the agar plate. During this study, several speciesof bacteria belonging to the genus bacteroides were reassignedto the newly described genera prevotella and porphyromonas.In this report, therefore, the term "bacteroides" includes speciesbelonging to any of the three genera.
Evaluation of Vaginal Smears
Vaginal smears were air dried, subjected to Gram's staining,and evaluated under magnification (x1000). A score of 0 to 10was assigned on the basis of the relative proportions of easilydistinguished bacterial morphologic types (i.e., large gram-positiverods, small gram-negative or variable rods, and curved rods).A score of 0 was assigned to the most lactobacillus-predominantvaginal flora, and a score of 10 was assigned to a flora inwhich lactobacilli were largely replaced by gardnerella, bacteroides,and mobiluncus. Scores for Gram's staining were calculated bythe method of Nugent et al.20
Diagnosis of Bacterial Vaginosis
Women with a vaginal pH above 4.5 and a score of 7 or more onGram's staining of the vaginal smear were considered to havebacterial vaginosis. The diagnosis was not disclosed to thewomen or their care providers. The investigators who interpretedthe results of the Gram's staining were not aware of the patients'clinical assessments. Data on the reproducibility of this method20and its relation to clinical signs have been published elsewhere.19
Definitions of Outcome
Estimates of gestational age were based on the date of the lastmenstrual period and were adjusted by the obstetrical provideras needed on the basis of the results of pregnancy tests andthe first pelvic examination, the fetal heartbeat, and availableresults of ultrasonography. If the date of a woman's last menstrualperiod was considered accurate, that date was the principalfactor used to estimate gestational age. If the date was notconsidered accurate, the clinical examination, history, andfindings of ultrasonography (if available) were used. No correctionsto the estimate of gestational age were made by the study personnel.Preterm delivery was defined as delivery at less than 37 weeks'gestation. An infant weighing less than 2500 g was defined ashaving a low birth weight. Premature rupture of membranes wasdefined as the rupture of membranes before the onset of regularuterine contractions.
Estimates of gestational age based on the date of the last menstrualperiod have known inaccuracies.21 Estimates based on exact menstrualhistories are accurate to within two weeks on either side ofthe estimated age, but those based on uncertain histories orexaminations performed in the second trimester are accurateonly to within four weeks.21 In our study, 10 percent of womencould not recall the month of their last menses, and among thosewho could do so, 55 percent presented for prenatal care in thesecond trimester and 19 percent presented after 20 weeks' gestation.Only 30 percent of the patients underwent ultrasonography beforeenrollment. Among the 10,397 women, 1193 (11.5 percent) deliveredbefore term (regardless of the infant's birth weight). However,only 504 infants (4.8 percent) were born prematurely with lowbirth weight, whereas the remaining 689 infants (6.6 percent)born at less than 37 weeks' gestation weighed 2500 g or more.These data suggested that many infants classified as prematureon the basis of the mother's last menstrual period may not havebeen premature. To correct for potential misclassification,the group of infants born prematurely was divided into thosewho had low birth weight and those who did not. The group withlow birth weight had a mean (±SD) gestational age of32.4±3.2 weeks and a mean birth weight of 1822±556g. In comparison, the group without low birth weight had a meangestational age of 35.0±1.5 weeks and a mean birth weightof 3054±393 g. In addition, the infants in the low-birth-weightgroup were significantly more likely than the other infantsto have respiratory distress syndrome (36 percent vs. 4 percent,P<0.001) and to spend more than one week in the neonatalintensive care unit (44 percent vs. 15 percent, P<0.001).The preponderance of serious sequelae among the infants bornprematurely occurred in the group with low birth weight.1 Thus,preterm delivery of an infant with low birth weight was theprimary outcome, both because it is clinically important andbecause it helped correct for any misclassification of gestationalage.
Statistical Analysis
Data were entered on forms and sent to the Data CoordinatingCenter, where the forms were edited and returned to the clinicalcenters for corrections as needed. Categorical variables werecompared by the chi-square test or Fisher's exact test.22 Woolf'smethod was used to calculate 95 percent confidence intervalsfor the univariate odds ratios.23 A two-tailed P value lessthan 0.05 was considered to indicate statistical significance.Multivariate analyses were performed with logistic-regressionprocedures that incorporated other variables predictive of thedelivery of an infant with low birth weight.
Results
Of the 10,397 women followed through delivery, 504 (4.8 percent)were delivered of premature infants with low birth weight. Thepreterm delivery of such an infant was associated with blackrace, primigravidity, prior delivery of an infant with low birthweight, loss of an earlier pregnancy, and smoking during thecurrent pregnancy (Table 1). Women who had urinary tract infectionsor used antibiotics before enrollment were also more likelyto deliver infants with low birth weight prematurely. The microorganismssignificantly associated with such deliveries included bacteroides,M. hominis,G. vaginalis,Ureaplasmaurealyticum, group B streptococci,Chlamydiatrachomatis, and Trichomonasvaginalis, whereas lactobacilluswas inversely associated with preterm delivery of an infantwith low birth weight.
Table 1. Association of Preterm Delivery of Low-Birth-Weight Infants and Bacterial Vaginosis with Demographic, Obstetrical, and Behavioral Characteristics and Genital Flora in 10,397 Pregnant Women.
Bacterial vaginosis was diagnosed in 1645 of the 10,397 women(16 percent). The prevalence of this condition ranged from 9to 28 percent among centers. The relations between demographic,obstetrical, and behavioral characteristics and genital floraand the presence of bacterial vaginosis are shown in Table 1.Characteristics significantly related to the presence of bacterialvaginosis included being black or Hispanic, being unmarried,and having an annual income less than $10,000. Among the womenwho had previously had live births, those with bacterial vaginosiswere more likely to have given birth to infants with low birthweights. Women who reported using antibiotics during the currentpregnancy but before their enrollment in the study and thosewho reported having yeast vaginitis were both less likely tohave bacterial vaginosis than women who did not use antibioticsand women without yeast vaginitis.
At enrollment, colonization with G. vaginalis, bacteroides,or M. hominis was associated with bacterial vaginosis (Table 1),as was colonization with U. urealyticum,C. trachomatis,or Neisseriagonorrhoeae. Colonization with lactobacilli, groupB streptococci, or Candidaalbicans was inversely associatedwith the presence of bacterial vaginosis.
Because the use of antibiotics could either eliminate bacterialvaginosis or modify its effect on the outcome of pregnancy,outcome data were restricted to women who did not use antibioticsduring the period after their enrollment and before 37 weeks'gestation. Outcome data on women who used oral metronidazole,ampicillin, amoxicillin, or intravaginal sulfa cream were notused, because these antibiotics are considered effective againstbacterial vaginosis.
The outcomes of pregnancy among women with bacterial vaginosiswho did not receive metronidazole, ampicillin, amoxicillin,or intravaginal sulfa cream are shown in Table 2. Bacterialvaginosis was associated with an increased risk of preterm deliveryof an infant with low birth weight (odds ratio, 1.5; 95 percentconfidence interval, 1.2 to 1.9). Bacterial vaginosis was alsorelated to a birth weight below 2500 g (odds ratio, 1.5) anda significantly reduced mean birth weight. Women who receivedantimicrobial agents from their primary care providers thatwere effective against bacterial vaginosis had the same incidenceof preterm delivery of infants with low birth weight as womenwithout bacterial vaginosis (8 of 187, or 4.3 percent). Therewas no association between bacterial vaginosis and prematurerupture of membranes (Table 2). A trend toward increased pretermdelivery of infants with low birth weights among women withbacterial vaginosis was observed at all study centers. If bacterialvaginosis was diagnosed on the basis of Gram's staining alone,the increase in the risk of preterm delivery of a low-birth-weightinfant (odds ratio, 1.4; 95 percent confidence interval, 1.2to 1.7) was similar to that found when both pH and Gram's stainingwere used. A vaginal pH above 4.5 was associated with the pretermdelivery of an infant with low birth weight only among womenwith bacterial vaginosis.
Table 2. Association of Bacterial Vaginosis with Outcomes of Pregnancy among Women without Trichomonas Who Did Not Receive Antibiotics between the Time of Enrollment in the Study and Delivery or 37 Weeks' Gestation.
Logistic regression was used to study the association betweenbacterial vaginosis and the preterm delivery of an infant withlow birth weight independently of other variables associatedwith such a delivery (Table 3). Bacterial vaginosis remainedindependently associated with the preterm delivery of a low-birth-weightinfant (odds ratio, 1.4; 95 percent confidence interval, 1.1to 1.8) after adjustment for smoking, race, any previous deliveryof a low-birth-weight infant, any loss of an earlier pregnancy,gravidity, maternal age, marital status, any use of antibiotics,and any colonization with C. trachomatis,N. gonorrhoeae,T.vaginalis, or group B streptococci. The excess risk of pretermdelivery of a low-birth-weight infant among women with bacterialvaginosis was unchanged in that model and was similar to therisks associated with cigarette smoking and black race. Deliveryof a low-birth-weight infant in the woman's preceding pregnancywas the factor most strongly associated with the premature deliveryof such an infant in the current pregnancy. In addition, havinglost an earlier pregnancy (because of either stillbirth or abortion,spontaneous or induced) and being a primigravida were also significantlyassociated with the preterm delivery of a low-birth-weight infant.
Table 3. Multivariate Analysis of Risk Factors for the Preterm Delivery of an Infant with Low Birth Weight among the 10,397 Women Enrolled in the Study.
G. vaginalis, bacteroides, and M. hominis were the microorganismsmost strongly associated with the presence of bacterial vaginosis.To evaluate the role of individual species in the associationbetween bacterial vaginosis and the preterm delivery of an infantwith low birth weight, we analyzed the incidence of such deliveriesin women with bacteroides and M. hominis after the women wereclassified as either having or not having bacterial vaginosis(Figure 1). The recovery of G. vaginalis had no effect on theincidence of preterm delivery of a low-birth-weight infant independentlyof the presence of bacterial vaginosis (data not shown). Inthe absence of bacteroides and M. hominis, women with bacterialvaginosis had no greater risk of giving birth prematurely tolow-birth-weight infants than the reference group of women whodid not have bacterial vaginosis or either microorganism (oddsratio, 0.8; 95 percent confidence interval, 0.4 to 1.6). Incontrast, women with bacterial vaginosis, bacteroides, and M.hominis had the highest incidence of preterm delivery of aninfant with low birth weight (odds ratio, 2.1; 95 percent confidenceinterval, 1.5 to 3.0) relative to the reference group. The presenceof either bacteroides or M. hominis was associated with pretermdelivery of a low-birth-weight infant (odds ratios, 1.5 and1.6, respectively), even in the absence of bacterial vaginosis.
Figure 1. Frequency of Preterm Delivery of an Infant with Low Birth Weight, According to Whether Bacterial Vaginosis Was Present and Whether Bacteroides and Mycoplasma hominis Were Recovered from the Mother's Vagina.
Odds ratios, followed in parentheses by 95 percent confidence intervals, are shown above each bar. The bar at the far left represents the reference group. The numbers inside the bars are the numbers of women in the groups. Women who received antibiotics were excluded from this analysis.
Discussion
In this study, women with bacterial vaginosis diagnosed duringthe second trimester of pregnancy were 40 percent more likelyto give birth to a premature, low-birth-weight infant than womenwithout bacterial vaginosis. The relation between bacterialvaginosis and such births remained unchanged after adjustmentfor confounding variables, which suggests that bacterial vaginosisis an independent risk factor for the preterm delivery of aninfant with low birth weight. The evidence that bacterial vaginosismay cause such births is strong. Criteria for assessing thecausal contributions of associated factors include the consistencyof the association among studies conducted under different circumstances;the magnitude of the relative risk; the demonstration that theexposure occurs before the outcome, showing a biologic gradientin which an increased exposure is associated with an increasedrisk of the abnormal outcome; and biologic plausibility. Theresults of this study together with those of other publishedstudies of bacterial vaginosis in pregnancy support a causalrole for this infection in prematurity.
Over the past decade, six studies have reported an increasedrisk of preterm delivery among women with bacterial vaginosis.5,6,7,8,9,10The appearance of this finding in casecontrol6,10 andcohort5,7,8,9 studies, conducted in the United States, Scandinavia,the United Kingdom, and Indonesia, meets the criterion of consistency.The risk of preterm delivery among women with bacterial vaginosis,which was found to be 1.4 in our study, ranged from 2.0 to 2.8in four other studies5,6,8,10 and was 3.5 and 6.9 in two additionalones.7,9 The highest risks were reported in cohort studies inwhich bacterial vaginosis was identified early in pregnancy.In our study, women were not enrolled until late in the secondtrimester, a fact that precluded the analysis of very earlyloss of pregnancy among women with bacterial vaginosis, whichmay account for the lower estimate of risk that we found.
Our study controlled for other risk factors for prematurityand simultaneously examined the roles of individual bacterialspecies and of bacterial vaginosis as risk factors for the pretermdelivery of an infant with low birth weight. Like earlier studiesreporting links between bacteroides, M. hominis, and pretermbirth,15,16,17 this study documented an increased risk of pretermdelivery of low-birth-weight infants among women colonized bythese microorganisms. In addition, we demonstrated that womenwith bacterial vaginosis and both pathogens are at the highestrisk for the preterm delivery of such infants (Figure 1).
The mechanism by which bacterial vaginosis causes the pretermbirth of an infant with low birth weight is not known, but thereis evidence that it causes infection of the upper genital tract,which in turn causes premature birth. In other studies, bacterialvaginosis has been associated with two- to threefold increasesin infection of amniotic fluid,5,14,24 infection of the chorionand amnion,11 and histologic chorioamnionitis.11 Pregnant womenwith bacterial vaginosis have elevated vaginal or cervical levelsof endotoxin,25 mucinase,26 sialidase,26 and interleukin-1,25suggesting that microorganisms that cause bacterial vaginosisstimulate the production of cytokines. A relative reductionin the number of vaginal lactobacilli is one characteristicof this syndrome. It is noteworthy that the presence of vaginallactobacilli appeared to protect against preterm delivery inthis study and an earlier one,15 further supporting the biologicplausibility of the hypothesis that bacterial vaginosis causesan increase in the preterm delivery of infants with low birthweight.
Bacterial vaginosis is one of the most common genital infectionsin pregnancy. From 12 to 22 percent of pregnant women have thissyndrome7,9; it was present in 16 percent of our study population,with a range of 9 to 28 percent among centers. Currently, pregnantwomen with asymptomatic bacterial vaginosis are not routinelyscreened or treated for this syndrome. Given the high frequencyof bacterial vaginosis, its treatment could have a substantialeffect on the incidence of preterm delivery of infants withlow birth weight. Although there is some concern about the useof systemic metronidazole because of potential carcinogenicity,27,28a recent analysis of seven studies suggested that there wasno increase in birth defects among infants exposed to metronidazoleduring the first trimester.29
The population attributable risk for the preterm delivery ofinfants with low birth weight that was accounted for by bacterialvaginosis in this observational study was 6 percent. The bestmethod of demonstrating a causal relation between bacterialvaginosis and such deliveries would be to conduct a randomizedclinical trial. In our study, bacterial vaginosis was relatedto very premature birth at a mean gestational age of 32 weeksand a mean birth weight of 1827 g. The prevention of even asmall proportion of such births could translate into large monetarysavings and a decrease in neonatal morbidity and mortality.
Supported by contracts (HD-3-2832 through HD-3-2836) from theNational Institute of Child Health and Human Development andby a contract (AI-4-2532) from the National Institute of Allergyand Infectious Diseases.
* Additional investigators are listed in the Appendix.
Source Information
From the University of Washington, Seattle (S.L.H., D.A.E., M.A. Krohn); the National Institute of Child Health and Human Development, Bethesda, Md. (R.P.N., D.M., M.A. Klebanoff); the University of Texas, San Antonio (R.G.); Louisiana State University, New Orleans (D.H.M., J.G.P.); the National Institute of Allergy and Infectious Diseases, Bethesda, Md. (M.F.C., R.E.); the Research Triangle Institute, Research Triangle Park, N.C. (A.V.R.); Columbia University, New York (J.A.R.); and the University of Oklahoma, Oklahoma City (J.C.C.).
Address reprint requests to Dr. Hillier at University of Pittsburgh/MageeWomen's Hospital, Department of Obstetrics, Gynecology, and Reproductive Sciences, 300 Halket St., Pittsburgh, PA 15213.
References
Increasing incidence of low birthweight -- United States, 1981-1991. MMWR Morb Mortal Wkly Rep 1994;43:335-339. [Medline]
Committee to Study the Prevention of Low Birth Weight, Division of Health Promotion and Disease Prevention, Institute of Medicine. Preventing low birthweight. Washington, D.C.: National Academy Press, 1985.
Hillier SL, Krohn MA, Rabe LK, Klebanoff SJ, Eschenbach DA. The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis 1993;16:Suppl 4:S273-S281.
Gravett MG, Nelson HP, DeRouen T, Critchlow CW, Eschenbach DA, Holmes KK. Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986;256:1899-1903. [Abstract]
Martius J, Krohn MA, Hillier SL, Stamm WE, Holmes KK, Eschenbach DA. Relationship of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol 1988;71:89-95. [Free Full Text]
Kurki T, Sivonen A, Renkonen OV, Savia E, Ylikorkala O. Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol 1992;80:173-177. [Free Full Text]
Riduan JM, Hillier SL, Utomo B, Wiknjosastro G, Linnan M, Kandun N. Bacterial vaginosis and prematurity in Indonesia: association in early and late pregnancy. Am J Obstet Gynecol 1993;169:175-178. [Medline]
Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994;308:295-298. [Free Full Text]
Holst E, Goffeng AR, Andersch B. Bacterial vaginosis and vaginal microorganisms in idiopathic premature labor and association with pregnancy outcome. J Clin Microbiol 1994;32:176-186. [Free Full Text]
Hillier SL, Martius J, Krohn MA, Kiviat NB, Holmes KK, Eschenbach DA. A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med 1988;319:972-978. [Abstract]
Silver HM, Sperling RS, St Clair PJ, Gibbs RS. Evidence relating bacterial vaginosis to intraamniotic infection. Am J Obstet Gynecol 1989;161:808-812. [Medline]
Gravett MG, Hummel D, Eschenbach DA, Holmes KK. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986;67:229-237. [Medline]
Hillier SL, Krohn MA, Cassen E, Rabe LK, Eschenbach DA. The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection among women in preterm labor with intact fetal membranes. Clin Infect Dis 1995;20:Suppl 2:S276-S278.
Krohn MA, Hillier SL, Lee ML, Rabe LK, Eschenbach DA. Vaginal Bacteroides species are associated with an increased rate of preterm delivery among women in preterm labor. J Infect Dis 1991;164:88-93. [Medline]
Minkoff H, Grunebaum AN, Schwarz RH, et al. Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy. Am J Obstet Gynecol 1984;150:965-972. [Medline]
Eschenbach DA, Nugent RP, Rao VJ, et al. A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery. Am J Obstet Gynecol 1991;164:734-742. [Medline]
Hillier SL, Krohn MA, Nugent RP, Gibbs RS. Characteristics of three vaginal flora patterns assessed by Gram stain among pregnant women. Am J Obstet Gynecol 1992;166:938-944. [Medline]
Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301. [Free Full Text]
Campbell S, Warsof SL, Little D, Cooper DJ. Routine ultrasound screening for the prediction of gestational age. Obstet Gynecol 1985;65:613-620. [Medline]
Armitage P, Berry G. Statistical methods in medical research. Boston: Blackwell Scientific, 1980:135-8.
Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251-253. [Medline]
Watts DH, Krohn MA, Hillier SL, Eschenbach DA. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992;79:351-357. [Medline]
Platz-Christensen JJ, Mattsby-Baltzer I, Thomsen P, Wiqvist N. Endotoxin and interleukin-1 alpha in the cervical mucus and vaginal fluid of pregnant women with bacterial vaginosis. Am J Obstet Gynecol 1993;169:1161-1166. [Medline]
McGregor JA, French JI, Jones W, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994;170:1048-1060. [Medline]
McDonald HM, O'Loughlin JA, Vigneswaran R, Jolley PT, McDonald PJ. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial. Obstet Gynecol 1994;84:343-348. [Free Full Text]
Robbie MO, Sweet RL. Metronidazole use in obstetrics and gynecology: a review. Am J Obstet Gynecol 1983;145:865-881. [Medline]
Burtin P, Taddio A, Arburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995;172:525-529. [CrossRef][Medline]
Appendix
In addition to the study authors, the following investigatorsand institutions participated in the Vaginal Infections andPrematurity Study Group: S.J. Yaffe, C.S. Catz, G.G. Rhoads,and H.W. Berendes (National Institute of Child Health and HumanDevelopment, Bethesda, Md.); W.C. Blackwelder, R.A. Kaslow,and G.F. Reed (National Institute for Allergy and InfectiousDiseases, Bethesda, Md.); E. Greenberg (Columbia University,New York); C. Cammarata (Louisiana State University, New Orleans);P. Sommers (Tulane University, New Orleans); P. Rettig and R.Wilkerson (University of Oklahoma, Oklahoma City); P. St. Clair(University of Texas, San Antonio); and W.K. Poole (ResearchTriangle Institute, Research Triangle Park, N.C.).
Oakley, B. B., Fiedler, T. L., Marrazzo, J. M., Fredricks, D. N.
(2008). Diversity of Human Vaginal Bacterial Communities and Associations with Clinically Defined Bacterial Vaginosis. Appl. Environ. Microbiol.
74: 4898-4909
[Abstract][Full Text]
Brotman, R. M., Klebanoff, M. A., Nansel, T. R., Andrews, W. W., Schwebke, J. R., Zhang, J., Yu, K. F., Zenilman, J. M., Scharfstein, D. O.
(2008). A Longitudinal Study of Vaginal Douching and Bacterial Vaginosis--A Marginal Structural Modeling Analysis. Am J Epidemiol
168: 188-196
[Abstract][Full Text]
TANYA NAGAHAWATTE, N., GOLDENBERG, R. L.
(2008). Poverty, Maternal Health, and Adverse Pregnancy Outcomes. Ann. N. Y. Acad. Sci.
1136: 80-85
[Abstract][Full Text]
Nygren, P., Fu, R., Freeman, M., Bougatsos, C., Klebanoff, M., Guise, J.-M.
(2008). Evidence on the Benefits and Harms of Screening and Treating Pregnant Women Who Are Asymptomatic for Bacterial Vaginosis: An Update Review for the U.S. Preventive Services Task Force. ANN INTERN MED
148: 220-233
[Abstract][Full Text]
Cherpes, T L, Marrazzo, J M, Cosentino, L A, Meyn, L A, Murray, P J, Hillier, S L
(2008). Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis. Sex. Transm. Infect.
84: 57-61
[Abstract][Full Text]
Marrazzo, J. M
(2007). Elusive aetiology of bacterial vaginosis. Do lesbians have a clue?. Sex. Transm. Infect.
83: 424-425
[Full Text]
Smith, L. K., Draper, E. S., Manktelow, B. N., Field, D. J.
(2007). Deprivation and Infection Among Spontaneous Very Preterm Births. Obstet Gynecol
110: 325-329
[Abstract][Full Text]
Robertson, S. A., Care, A. S., Skinner, R. J.
(2007). Interleukin 10 Regulates Inflammatory Cytokine Synthesis to Protect Against Lipopolysaccharide-Induced Abortion and Fetal Growth Restriction in Mice. Biol. Reprod.
76: 738-748
[Abstract][Full Text]
Cauci, S., Di Santolo, M., Casabellata, G., Ryckman, K., Williams, S. M., Guaschino, S.
(2007). Association of interleukin-1{beta} and interleukin-1 receptor antagonist polymorphisms with bacterial vaginosis in non-pregnant Italian women. Mol Hum Reprod
13: 243-250
[Abstract][Full Text]
Allsworth, J. E., Peipert, J. F.
(2007). Prevalence of Bacterial Vaginosis: 2001 2004 National Health and Nutrition Examination Survey Data. Obstet Gynecol
109: 114-120
[Abstract][Full Text]
Keane, F, Ison, C A, Noble, H, Estcourt, C
(2006). Bacterial vaginosis. Sex. Transm. Infect.
82: iv16-iv18
[Full Text]
MOUTSOPOULOS, N. M, MADIANOS, P. N
(2006). Low-Grade Inflammation in Chronic Infectious Diseases: Paradigm of Periodontal Infections. Ann. N. Y. Acad. Sci.
1088: 251-264
[Abstract][Full Text]
Tann, C J, Mpairwe, H, Morison, L, Nassimu, K, Hughes, P, Omara, M, Mabey, D, Muwanga, M, Grosskurth, H, Elliott, A M
(2006). Lack of effectiveness of syndromic management in targeting vaginal infections in pregnancy in Entebbe, Uganda.. Sex. Transm. Infect.
82: 285-289
[Abstract][Full Text]
Roberton, A. M., Wiggins, R., Horner, P. J., Greenwood, R., Crowley, T., Fernandes, A., Berry, M., Corfield, A. P.
(2005). A Novel Bacterial Mucinase, Glycosulfatase, Is Associated with Bacterial Vaginosis. J. Clin. Microbiol.
43: 5504-5508
[Abstract][Full Text]
Thompson, L. A., Goodman, D. C., Chang, C.-H., Stukel, T. A.
(2005). Regional Variation in Rates of Low Birth Weight. Pediatrics
116: 1114-1121
[Abstract][Full Text]
Waites, K. B., Katz, B., Schelonka, R. L.
(2005). Mycoplasmas and Ureaplasmas as Neonatal Pathogens. Clin. Microbiol. Rev.
18: 757-789
[Abstract][Full Text]
Austin, M. N., Beigi, R. H., Meyn, L. A., Hillier, S. L.
(2005). Microbiologic Response to Treatment of Bacterial Vaginosis with Topical Clindamycin or Metronidazole. J. Clin. Microbiol.
43: 4492-4497
[Abstract][Full Text]
Mullick, S, Watson-Jones, D, Beksinska, M, Mabey, D
(2005). Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex. Transm. Infect.
81: 294-302
[Abstract][Full Text]
Bradshaw, C. S., Morton, A. N., Garland, S. M., Morris, M. B., Moss, L. M., Fairley, C. K.
(2005). Higher-Risk Behavioral Practices Associated With Bacterial Vaginosis Compared With Vaginal Candidiasis. Obstet Gynecol
106: 105-114
[Abstract][Full Text]
Okun, N., Gronau, K. A., Hannah, M. E.
(2005). Antibiotics for Bacterial Vaginosis or Trichomonas vaginalis in Pregnancy: A Systematic Review. Obstet Gynecol
105: 857-868
[Abstract][Full Text]
Bradshaw, C. S., Morton, A. N., Garland, S. M., Horvath, L. B., Kuzevska, I., Fairley, C. K.
(2005). Evaluation of a Point-of-Care Test, BVBlue, and Clinical and Laboratory Criteria for Diagnosis of Bacterial Vaginosis. J. Clin. Microbiol.
43: 1304-1308
[Abstract][Full Text]
Bhutta, Z. A., Darmstadt, G. L., Hasan, B. S., Haws, R. A.
(2005). Community-Based Interventions for Improving Perinatal and Neonatal Health Outcomes in Developing Countries: A Review of the Evidence. Pediatrics
115: 519-617
[Abstract][Full Text]
Ramsey, P. S., Lyon, M. D., Goepfert, A. R., Cliver, S., Schwebke, J., Andrews, W. W., Goldenberg, R. L., Hauth, J. C.
(2005). Use of Vaginal Polymorphonuclear to Epithelial Cell Ratios for the Prediction of Preterm Birth. Obstet Gynecol
105: 139-144
[Abstract][Full Text]
Ferris, M. J., Masztal, A., Martin, D. H.
(2004). Use of Species-Directed 16S rRNA Gene PCR Primers for Detection of Atopobium vaginae in Patients with Bacterial Vaginosis. J. Clin. Microbiol.
42: 5892-5894
[Abstract][Full Text]
Chaudry, A. N., Travers, P. J., Yuenger, J., Colletta, L., Evans, P., Zenilman, J. M., Tummon, A.
(2004). Analysis of Vaginal Acetic Acid in Patients Undergoing Treatment for Bacterial Vaginosis. J. Clin. Microbiol.
42: 5170-5175
[Abstract][Full Text]
Ugwumadu, A., Reid, F., Hay, P., Manyonda, I.
(2004). Natural History of Bacterial Vaginosis and Intermediate Flora in Pregnancy and Effect of Oral Clindamycin. Obstet Gynecol
104: 114-119
[Abstract][Full Text]
Yudin, M. H., Landers, D. V., Meyn, L., Hillier, S. L.
(2003). Clinical and Cervical Cytokine Response to Treatment With Oral or Vaginal Metronidazole for Bacterial Vaginosis During Pregnancy: A Randomized Trial. Obstet Gynecol
102: 527-534
[Abstract][Full Text]
Ahern, J, Pickett, K E, Selvin, S, Abrams, B
(2003). Preterm birth among African American and white women: a multilevel analysis of socioeconomic characteristics and cigarette smoking. J. Epidemiol. Community Health
57: 606-611
[Abstract][Full Text]
Reid, G, Bruce, A W
(2003). Urogenital infections in women: can probiotics help?. Postgrad. Med. J.
79: 428-432
[Abstract][Full Text]
Yoshida, T., Maeda, S.-I., Deguchi, T., Miyazawa, T., Ishiko, H.
(2003). Rapid Detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticum Organisms in Genitourinary Samples by PCR-Microtiter Plate Hybridization Assay. J. Clin. Microbiol.
41: 1850-1855
[Abstract][Full Text]
Myziuk, L., Romanowski, B., Johnson, S. C.
(2003). BVBlue Test for Diagnosis of Bacterial Vaginosis. J. Clin. Microbiol.
41: 1925-1928
[Abstract][Full Text]
Onderdonk, A. B., Lee, M.-L., Lieberman, E., Delaney, M. L., Tuomala, R. E.
(2003). Quantitative Microbiologic Models for Preterm Delivery. J. Clin. Microbiol.
41: 1073-1079
[Abstract][Full Text]
Lamont, R. F., Duncan, S. L. B., Mandal, D., Bassett, P.
(2003). Intravaginal Clindamycin to Reduce Preterm Birth in Women With Abnormal Genital Tract Flora. Obstet Gynecol
101: 516-522
[Abstract][Full Text]
Cauci, S., Thorsen, P., Schendel, D. E., Bremmelgaard, A., Quadrifoglio, F., Guaschino, S.
(2003). Determination of Immunoglobulin A against Gardnerella vaginalis Hemolysin, Sialidase, and Prolidase Activities in Vaginal Fluid: Implications for Adverse Pregnancy Outcomes. J. Clin. Microbiol.
41: 435-438
[Abstract][Full Text]
Cauci, S., Guaschino, S., de Aloysio, D., Driussi, S., De Santo, D., Penacchioni, P., Quadrifoglio, F.
(2003). Interrelationships of interleukin-8 with interleukin-1{beta} and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod
9: 53-58
[Abstract][Full Text]
Nelson, D. B., Macones, G.
(2002). Bacterial Vaginosis in Pregnancy: Current Findings and Future Directions. Epidemiol Rev
24: 102-108
[Full Text]
Martino, J. L., Vermund, S. H.
(2002). Vaginal Douching: Evidence for Risks or Benefits to Women's Health. Epidemiol Rev
24: 109-124
[Full Text]
Workowski, K. A., Levine, W. C., Wasserheit, J. N.
(2002). U.S. Centers for Disease Control and Prevention Guidelines for the Treatment of Sexually Transmitted Diseases: An Opportunity To Unify Clinical and Public Health Practice. ANN INTERN MED
137: 255-262
[Abstract][Full Text]
Ruiz, R. J., Fullerton, J., Brown, C. E. L., Dudley, D. J.
(2002). Predicting Risk of Preterm Birth: The Roles of Stress, Clinical Risk Factors, and Corticotropin-Releasing Hormone. Biol Res Nurs
4: 54-64
[Abstract]
Cauci, S., Driussi, S., De Santo, D., Penacchioni, P., Iannicelli, T., Lanzafame, P., De Seta, F., Quadrifoglio, F., de Aloysio, D., Guaschino, S.
(2002). Prevalence of Bacterial Vaginosis and Vaginal Flora Changes in Peri- and Postmenopausal Women. J. Clin. Microbiol.
40: 2147-2152
[Abstract][Full Text]
Yoshida, T., Maeda, S.-I., Deguchi, T., Ishiko, H.
(2002). Phylogeny-Based Rapid Identification of Mycoplasmas and Ureaplasmas from Urethritis Patients. J. Clin. Microbiol.
40: 105-110
[Abstract][Full Text]
Holzman, C., Leventhal, J. M., Qiu, H., Jones, N. M., Wang, J.
(2001). Factors Linked to Bacterial Vaginosis in Nonpregnant Women. Am. J. Public Health
91: 1664-1670
[Abstract][Full Text]
Delaney, M. L., Onderdonk, A. B.
(2001). Nugent Score Related to Vaginal Culture in Pregnant Women. Obstet Gynecol
98: 79-84
[Abstract][Full Text]
KEKKI, M., KURKI, T., PELKONEN, J., KURKINEN-RATY, M., CACCIATORE, B., PAAVONEN, J.
(2001). Vaginal Clindamycin in Preventing Preterm Birth and Peripartal Infections in Asymptomatic Women With Bacterial Vaginosis: A Randomized, Controlled Trial. Obstet Gynecol
97: 643-648
[Abstract][Full Text]
Shahmanesh, M.
(2001). Why common things are common: the tale of non-gonococcal urethritis. Sex. Transm. Infect.
77: 139-140
[Full Text]
Schulpen, T W J, van Steenbergen, J E, van Driel, H F
(2001). Influences of ethnicity on perinatal and child mortality in the Netherlands. Arch. Dis. Child.
84: 222-226
[Abstract][Full Text]
Morris, M C, Rogers, P A, Kinghorn, G R
(2001). Is bacterial vaginosis a sexually transmitted infection?. Sex. Transm. Infect.
77: 63-68
[Abstract][Full Text]
Kilic, A. O., Pavlova, S. I., Alpay, S., Kilic, S. S., Tao, L.
(2001). Comparative Study of Vaginal Lactobacillus Phages Isolated from Women in the United States and Turkey: Prevalence, Morphology, Host Range, and DNA Homology. CVI
8: 31-39
[Abstract][Full Text]
Li, X., Kolltveit, K. M., Tronstad, L., Olsen, I.
(2000). Systemic Diseases Caused by Oral Infection. Clin. Microbiol. Rev.
13: 547-558
[Abstract][Full Text]
MASTROBATTISTA, J. M., BISHOP, K. D., NEWTON, E. R.
(2000). Wet Smear Compared With Gram Stain Diagnosis of Bacterial Vaginosis in Asymptomatic Pregnant Women. Obstet Gynecol
96: 504-506
[Abstract][Full Text]
Marrazzo, J. M
(2000). Sexually transmitted infections in women who have sex with women: who cares?. Sex. Transm. Infect.
76: 330-332
[Full Text]
Jarosik, G. P., Land, C. B.
(2000). Identification of a Human Lactoferrin-Binding Protein in Gardnerella vaginalis. Infect. Immun.
68: 3443-3447
[Abstract][Full Text]
Goldenberg, R. L., Hauth, J. C., Andrews, W. W.
(2000). Intrauterine Infection and Preterm Delivery. NEJM
342: 1500-1507
[Full Text]
KURKI, T., HIILESMAA, V., RAITASALO, R., MATTILA, H., YLIKORKALA, O.
(2000). Depression and Anxiety in Early Pregnancy and Risk for Preeclampsia. Obstet Gynecol
95: 487-490
[Abstract][Full Text]
Carey, J. C., Klebanoff, M. A., Hauth, J. C., Hillier, S. L., Thom, E. A., Ernest, J.M., Heine, R. P., Nugent, R. P., Fischer, M. L., Leveno, K. J., Wapner, R., Varner, M., Trout, W., Moawad, A., Sibai, B. M., Miodovnik, M., Dombrowski, M., O'Sullivan, M. J., VanDorsten, J. P., Langer, O., Roberts, J., The National Institute of Child Health Human Devel,
(2000). Metronidazole to Prevent Preterm Delivery in Pregnant Women with Asymptomatic Bacterial Vaginosis. NEJM
342: 534-540
[Abstract][Full Text]
Sanders, M. E.
(2000). Considerations for Use of Probiotic Bacteria to Modulate Human Health. J. Nutr.
130: 384-384
[Abstract][Full Text]
Mackler, A. M., Ducsay, C. A., Veldhuis, J. D., Yellon, S. M.
(1999). Maturation of Spontaneous and Agonist-Induced Uterine Contractions in the Peripartum Mouse Uterus. Biol. Reprod.
61: 873-878
[Abstract][Full Text]
Mackler, A.M., Iezza, G., Akin, M.R., McMillan, P., Yellon, S.M.
(1999). Macrophage Trafficking in the Uterus and Cervix Precedes Parturition in the Mouse. Biol. Reprod.
61: 879-883
[Abstract][Full Text]
Norwitz, E. R., Robinson, J. N., Challis, J. R.G.
(1999). The Control of Labor. NEJM
341: 660-666
[Full Text]
Merchant, J. S., Oh, M. K., Klerman, L. V.
(1999). Douching: A Problem for Adolescent Girls and Young Women. Arch Pediatr Adolesc Med
153: 834-837
[Abstract][Full Text]
Ralph, S G, Rutherford, A J, Wilson, J D
(1999). Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. BMJ
319: 220-223
[Abstract][Full Text]
Nowicki, B., Singhal, J., Fang, L., Nowicki, S., Yallampalli, C.
(1999). Inverse Relationship between Severity of Experimental Pyelonephritis and Nitric Oxide Production in C3H/HeJ Mice. Infect. Immun.
67: 2421-2427
[Abstract][Full Text]
Pal, S., Peterson, E. M., de la Maza, L. M.
(1999). A Murine Model for the Study of Chlamydia trachomatis Genital Infections during Pregnancy. Infect. Immun.
67: 2607-2610
[Abstract][Full Text]
FRENCH, J. I., MCGREGOR, J. A., DRAPER, D., PARKER, R., MCFEE, J.
(1999). Gestational Bleeding, Bacterial Vaginosis, and Common Reproductive Tract Infections: Risk for Preterm Birth and Benefit of Treatment. Obstet Gynecol
93: 715-724
[Abstract][Full Text]
CRANE, J. M. G., ANTHONY ARMSON, B., DODDS, L., FEINBERG, R. F., KENNEDY, W., KIRKLAND, S. A.
(1999). Risk Scoring, Fetal Fibronectin, and Bacterial Vaginosis to Predict Preterm Delivery. Obstet Gynecol
93: 517-522
[Abstract][Full Text]
Brocklehurst, P.
(1999). Infection and preterm delivery. BMJ
318: 548-549
[Full Text]
PASTORE, L. M., ROYCE, R. A., JACKSON, T. P., THORP, J. M. Jr, SAVITZ, D. A., KREADEN, U. S.
(1999). Association Between Bacterial Vaginosis and Fetal Fibronectin at 24-29 Weeks' Gestation. Obstet Gynecol
93: 117-123
[Abstract][Full Text]
Kogan, M. D., Martin, J. A., Ventura, S. J., Alexander, G. R., Kotelchuck, M., Frigoletto, F. D., Rosenberg, K. D., Rooks, J. P., Misra, D. P., Guyer, B., Kogan, M. D., Martin, J. A., Ventura, S. J., Alexander, G. R., Kotelchuck, M., Frigoletto, F. D.
(1998). Benefits and Limitations of Prenatal Care. JAMA
280: 2071-2073
[Full Text]
Jarosik, G. P., Land, C. B., Duhon, P., Chandler, R. Jr., Mercer, T.
(1998). Acquisition of Iron by Gardnerella vaginalis. Infect. Immun.
66: 5041-5047
[Abstract][Full Text]
Goldenberg, R. L., Rouse, D. J.
(1998). Prevention of Premature Birth. NEJM
339: 313-320
[Full Text]
Schuchat, A.
(1998). Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms. Clin. Microbiol. Rev.
11: 497-513
[Abstract][Full Text]
Muli, F., Struthers, J. K.
(1998). Use of a Continuous-Culture Biofilm System To Study the Antimicrobial Susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus. Antimicrob. Agents Chemother.
42: 1428-1432
[Abstract][Full Text]
Darveau, R. P., Belton, C. M., Reife, R. A., Lamont, R. J.
(1998). Local Chemokine Paralysis, a Novel Pathogenic Mechanism for Porphyromonas gingivalis. Infect. Immun.
66: 1660-1665
[Abstract][Full Text]
Murdoch, D. A.
(1998). Gram-Positive Anaerobic Cocci. Clin. Microbiol. Rev.
11: 81-120
[Abstract][Full Text]
McGregor, J. A., French, J. I., Bloom, B. S., Lee, D. W., Hauth, J. C., Hillier, S. L.
(1996). Bacterial Vaginosis and Preterm Birth. NEJM
334: 1337-1339
[Full Text]
(1996). BACTERIAL VAGINOSIS AND PRETERM DELIVERY. JWatch General
1996: 1-1
[Full Text]
Hack, M., Merkatz, I. R.
(1995). Preterm Delivery and Low Birth Weight -- A Dire Legacy. NEJM
333: 1772-1774
[Full Text]